Delivery Order SPE2DB20D2104-SPE2DB24FMAQE

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award, valued at $2,274.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of 4,565,134,472 units of Ciprofloxacin HCL 500 mg tablets. This is a firm-fixed-price delivery order contract with a period of performance through July 15, 2024. The contract is not designated as a set-aside and was likely awarded through open competition. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery...
This federal contract award is for the delivery of 4,558,280,789 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,032.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 30, 2022, with an ultimate completion date of August 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.86, is a delivery order for 4,559,295,117 units of Ciprofloxacin HCL 250 MG Tablets. It is a firm-fixed price contract with a completion date of December 8, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,924.14, is a firm fixed-price delivery order for 4,567,222,463 units of Ciprofloxacin HCL 500 mg tablets. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,548.05, is for the delivery of 4,562,594,736 units of Ciprofloxacin HCL 500 mg tablets. The contract is a firm fixed-price delivery order that runs through October 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $2,390.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,566,556,792 units of Ciprofloxacin HCL 250 mg tablets, with an ultimate completion date of November 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.93 firm fixed-price delivery order provides Ciprofloxacin HCL 250 mg tablets to support military healthcare programs. The contract has an ultimate completion date of February 11, 2025 and is not designated with a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,549.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Ciprofloxacin HCL 250 mg tablets to support military and federal healthcare programs. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,070.52 Firm Fixed Price Delivery Order contract is for the supply of 4,563,849,299 units of Ciprofloxacin HCL 500 mg tablets. The contract has a period of performance through March 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.38 firm fixed-price delivery order is for the supply of 4,560,762,537 units of Ciprofloxacin HCL 250 mg tablets. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FMAQE
    Delivery Order

This federal contract award, valued at $4,262.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,565,659,772 units of Ciprofloxacin HCL 250 mg tablets, with an ultimate completion date of September 4, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:50 AM